[1]	Storr HL, Freer J, Child J, et al. Assessment of childhood short stature: a GP guide[J]. Br J Gen Pract, 2023, 73(729): 184-186. PMCID: PMC10049590. DOI: 10.3399/bjgp23X732525 . https://www.ncbi.nlm.nih.gov/pubmed/36997204 Cited in this article [1]

[2]	Li F, Liu K, Zhao Q, et al. Prevalence of short stature among children in China: a systematic review[J]. Pediatr Investig, 2021, 5(2): 140-147. PMCID: PMC8212717. DOI: 10.1002/ped4.12233 . https://www.ncbi.nlm.nih.gov/pubmed/34179712 Cited in this article [1]

[3]	Faienza MF, Chiarito M, Brunetti G, et al. Growth plate gene involvement and isolated short stature[J]. Endocrine, 2021, 71(1): 28-34. DOI: 10.1007/s12020-020-02362-w . https://www.ncbi.nlm.nih.gov/pubmed/32504378 Cited in this article [2]

[4]

Maghnie M, Ranke MB, Geffner ME, et al. Safety and efficacy of pediatric growth hormone therapy: results from the full KIGS cohort[J]. J Clin Endocrinol Metab, 2022, 107(12): 3287-3301. PMCID: PMC9693805. DOI: 10.1210/clinem/dgac517 . https://www.ncbi.nlm.nih.gov/pubmed/36102184 Cited in this article [2]

[5]	Paton DM. Efficacy of vosoritide in the treatment of achondroplasia[J]. Drugs Today (Barc), 2022, 58(9): 451-456. DOI: 10.1358/dot.2022.58.9.3422313 . https://www.ncbi.nlm.nih.gov/pubmed/36102905 Cited in this article [2]

[6]

Yuan J, Wang Y, Huang Y, et al. Investigating novel therapeutic approaches for idiopathic short stature: targeting siRNA and growth hormone delivery to the growth plate using exosome nanoparticles[J]. Adv Sci (Weinh), 2024, 11(24): e2309559. PMCID: PMC11200009. DOI: 10.1002/advs.202309559 . https://www.ncbi.nlm.nih.gov/pubmed/38639394 Cited in this article [1]

[7]	Sia KC, Gan SU, Mohd Rodhi SH, et al. First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model[J]. Gene Ther, 2022, 29(6): 346-356. PMCID: PMC9203273. DOI: 10.1038/s41434-022-00313-w . https://www.ncbi.nlm.nih.gov/pubmed/35105948 Cited in this article [2]

[8]	Hunziker EB. Growth plate structure and function[J]. Pathol Immunopathol Res, 1988, 7(1-2): 9-13. DOI: 10.1159/000157084 . https://www.ncbi.nlm.nih.gov/pubmed/3065770 Cited in this article [1]

[9]

Long JT, Leinroth A, Liao Y, et al. Hypertrophic chondrocytes serve as a reservoir for marrow-associated skeletal stem and progenitor cells, osteoblasts, and adipocytes during skeletal development[J]. Elife, 2022, 11: e76932. PMCID: PMC8893718. DOI: 10.7554/eLife.76932 . https://www.ncbi.nlm.nih.gov/pubmed/35179487

[10]

Bendre A, Ottosson L, Baroncelli M, et al. Growth failure in aggrecan deficiency is due to decreased extracellular matrix and impaired growth plate chondrocyte hypertrophy[J]. Bone, 2025, 200: 117594. DOI: 10.1016/j.bone.2025.117594 . https://www.ncbi.nlm.nih.gov/pubmed/40685060 Cited in this article [2]

[11]

Brylka LJ, Alimy AR, Tschaffon-Müller MEA, et al. Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development[J]. Bone Res, 2024, 12(1): 12. PMCID: PMC10891122. DOI: 10.1038/s41413-024-00315-x . https://www.ncbi.nlm.nih.gov/pubmed/38395992 Cited in this article [1]

[12]	Sarver DC, Garcia-Diaz J, Saqib M, et al. Tmem263 deletion disrupts the GH/IGF-1 axis and causes dwarfism and impairs skeletal acquisition[J]. Elife, 2024, 12: RP90949. PMCID: PMC10945605. DOI: 10.7554/eLife.90949 . https://www.ncbi.nlm.nih.gov/pubmed/38241182 Cited in this article [1]

[13]

Haris B, Mohammed I, Ismail Umlai UK, et al. Severe growth hormone deficiency in an Indian boy caused by a novel 6 kb homozygous deletion spanning the GH1 gene[J]. J Clin Res Pediatr Endocrinol, 2024, 16(2): 229-234. PMCID: PMC11590716. DOI: 10.4274/jcrpe.galenos.2022.2022-5-9 . https://www.ncbi.nlm.nih.gov/pubmed/36728277 Cited in this article [1]

[14]

Shabbir RMK, Nalbant G, Zaman Q, et al. A recurrent mutation in growth hormone receptor (GHR) gene underlying laron-type dwarfism in a Pakistani family[J]. Yale J Biol Med, 2023, 96(3): 313-325. PMCID: PMC10524814. DOI: 10.59249/tcaa2040 . https://www.ncbi.nlm.nih.gov/pubmed/37780997 Cited in this article [1]

[15]

Giacomozzi C, Martin A, Fernández MC, et al. Novel insulin-like growth factor 1 gene mutation: broadening of the phenotype and implications for insulin resistance[J]. J Clin Endocrinol Metab, 2023, 108(6): 1355-1369. DOI: 10.1210/clinem/dgac738 . https://www.ncbi.nlm.nih.gov/pubmed/36546343 Cited in this article [1]

[16]	Weise M, De-Levi S, Barnes KM, et al. Effects of estrogen on growth plate senescence and epiphyseal fusion[J]. Proc Natl Acad Sci U S A, 2001, 98(12): 6871-6876. PMCID: PMC34445. DOI: 10.1073/pnas.121180498 . https://www.ncbi.nlm.nih.gov/pubmed/11381135 Cited in this article [2]

[17]

Imre E, Akçay S, Yavuz DG. Aromatase enzyme deficiency in an adult male patient and the effects of estrogen replacement therapy: a rare cause of tall stature[J]. Hormones (Athens), 2025, 24(2): 525-532. DOI: 10.1007/s42000-025-00640-8 . https://www.ncbi.nlm.nih.gov/pubmed/40048086 Cited in this article [1]

[18]

Reno PL, Wallace S, Doelp SN, et al. The role of the PTHrP/Ihh feedback loop in the unusual growth plate location in mammalian metatarsals and pisiforms[J]. Dev Dyn, 2025, 254(12): 1307-1324. PMCID: PMC12678681. DOI: 10.1002/dvdy.70013 . https://www.ncbi.nlm.nih.gov/pubmed/40088130 Cited in this article [1]

[19]	Saeed T, Bibi N, Ahmad A, et al. A novel biallelic variant in IHH causing acrocapitofemoral dysplasia in a Pakistani family[J]. Mol Genet Genomic Med, 2025, 13(3): e70085. PMCID: PMC11883292. DOI: 10.1002/mgg3.70085 . https://www.ncbi.nlm.nih.gov/pubmed/40045933 Cited in this article [1]

[20]

Sun J, Yang N, Xu Z, et al. A novel heterozygous mutation in PTHLH causing autosomal dominant brachydactyly type E complicated with short stature[J]. Mol Genet Genomic Med, 2024, 12(2): e2393. PMCID: PMC10844838. DOI: 10.1002/mgg3.2393 . https://www.ncbi.nlm.nih.gov/pubmed/38407575 Cited in this article [1]

[21]

Sahni M, Ambrosetti DC, Mansukhani A, et al. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway[J]. Genes Dev, 1999, 13(11): 1361-1366. PMCID: PMC316762. DOI: 10.1101/gad.13.11.1361 . https://www.ncbi.nlm.nih.gov/pubmed/10364154 Cited in this article [1]

[22]

Murakami S, Balmes G, Mckinney S, et al. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype[J]. Genes Dev, 2004, 18(3): 290-305. PMCID: PMC338282. DOI: 10.1101/gad.1179104 . https://www.ncbi.nlm.nih.gov/pubmed/14871928 Cited in this article [1]

[23]	顾世立, 应令雯, 常国营, 等. FGFR3基因变异所致疾病的临床特征及基因变异分析[J]. 中国当代儿科杂志, 2025, 27(10): 1259-1265. PMCID: PMC12548657. DOI: 10.7499/j.issn.1008-8830.2504002 . https://www.ncbi.nlm.nih.gov/pubmed/41121704 Cited in this article [1]

[24]

Chen J, He D, Yuan C, et al. Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy[J]. J Orthop Translat, 2025, 51: 68-81. PMCID: PMC11847030. DOI: 10.1016/j.jot.2025.01.011 . https://www.ncbi.nlm.nih.gov/pubmed/39991457 Cited in this article [1]

[25]	Yasoda A, Komatsu Y, Chusho H, et al. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway[J]. Nat Med, 2004, 10(1): 80-86. DOI: 10.1038/nm971 . https://www.ncbi.nlm.nih.gov/pubmed/14702637 Cited in this article [2]

[26]	Hisado-Oliva A, Ruzafa-Martin A, Sentchordi L, et al. Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature[J]. Genet Med, 2018, 20(1): 91-97. DOI: 10.1038/gim.2017.66 . https://www.ncbi.nlm.nih.gov/pubmed/28661490 Cited in this article [1]

[27]

Badawi S, Varghese DS, Raj A, et al. Unveiling the pathogenic mechanisms of NPR2 missense variants: insights into the genotype-associated severity in acromesomelic dysplasia and short stature[J]. Front Cell Dev Biol, 2023, 11: 1294748. PMCID: PMC10702138. DOI: 10.3389/fcell.2023.1294748 . https://www.ncbi.nlm.nih.gov/pubmed/38078000 Cited in this article [1]

[28]	Oichi T, Taniguchi Y, Soma K, et al. Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway[J]. Cell Mol Life Sci, 2019, 76(23): 4795-4809. PMCID: PMC11105417. DOI: 10.1007/s00018-019-03188-0 . https://www.ncbi.nlm.nih.gov/pubmed/31201465 Cited in this article [1]

[29]

Iwai T, Murai J, Yoshikawa H, et al. Smad7 inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways[J]. J Biol Chem, 2008, 283(40): 27154-27164. DOI: 10.1074/jbc.M801175200 . https://www.ncbi.nlm.nih.gov/pubmed/18644788 Cited in this article [1]

[30]	Priestley JRC, Deshwar AR, Murthy H, et al. Monoallelic loss-of-function BMP2 variants result in BMP2-related skeletal dysplasia spectrum[J]. Genet Med, 2023, 25(8): 100863. DOI: 10.1016/j.gim.2023.100863 . https://www.ncbi.nlm.nih.gov/pubmed/37125634 Cited in this article [1]

[31]	Akiyama H, Lyons JP, Mori-Akiyama Y, et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation[J]. Genes Dev, 2004, 18(9): 1072-1087. PMCID: PMC406296. DOI: 10.1101/gad.1171104 . https://www.ncbi.nlm.nih.gov/pubmed/15132997 Cited in this article [1]

[32]

Nunes-Xavier CE, Pallarès-Sastre M, Rodríguez-Ramos A, et al. Genotype-phenotype characterization and functional reconstitution of pathogenic β-catenin variants from CTNNB1 syndrome patients[J]. PLoS Genet, 2025, 21(10): e1011907. PMCID: PMC12543288. DOI: 10.1371/journal.pgen.1011907 . https://www.ncbi.nlm.nih.gov/pubmed/41082542 Cited in this article [1]

[33]	Gao B, Song H, Bishop K, et al. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2[J]. Dev Cell, 2011, 20(2): 163-176. PMCID: PMC3062198. DOI: 10.1016/j.devcel.2011.01.001 . https://www.ncbi.nlm.nih.gov/pubmed/21316585 Cited in this article [1]

[34]	Zhu H, Chen Y, Niu Y, et al. A novel variant in WNT5A responsible for Robinow syndrome in a male fetus with limb shortening and agenesis of the penis[J]. Clin Dysmorphol, 2022, 31(2): 71-73. DOI: 10.1097/MCD.0000000000000401 . https://www.ncbi.nlm.nih.gov/pubmed/34750320 Cited in this article [1]

[35]

Tong WX, Chen HJ, Huang ZL, et al. PTHrP buffers Wnt/β- catenin activity through a PKC-ζ involved negative feedback loop to maintain articular cartilage homeostasis and attenuate osteoarthritis[J]. J Orthop Translat, 2025, 54: 65-76. PMCID: PMC12304701. DOI: 10.1016/j.jot.2025.03.012 . https://www.ncbi.nlm.nih.gov/pubmed/40735514 Cited in this article [1]

[36]	Zhou S, Xie Y, Tang J, et al. FGFR3 deficiency causes multiple chondroma-like lesions by upregulating hedgehog signaling[J]. PLoS Genet, 2015, 11(6): e1005214. PMCID: PMC4474636. DOI: 10.1371/journal.pgen.1005214 . https://www.ncbi.nlm.nih.gov/pubmed/26091072 Cited in this article [1]

[37]

Qi H, Jin M, Duan Y, et al. FGFR3 induces degradation of BMP type I receptor to regulate skeletal development[J]. Biochim Biophys Acta Mol Cell Res, 2014, 1843(7): 1237-1247. PMCID: PMC4111238. DOI: 10.1016/j.bbamcr.2014.03.011 . https://www.ncbi.nlm.nih.gov/pubmed/24657641 Cited in this article [1]

[38]	Melrose J, Shu C, Whitelock JM, et al. The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation[J]. Matrix Biol, 2016, 52-54: 363-383. DOI: 10.1016/j.matbio.2016.01.008 . https://www.ncbi.nlm.nih.gov/pubmed/26807757 Cited in this article [1]

[39]	Fan L, Ji L, Xu Y, et al. A novel mutation c.3392G>T of COL2A1 causes spondyloepiphyseal dysplasia congenital by affecting pre-mRNA splicing[J]. Front Genet, 2022, 13: 827560. PMCID: PMC9174977. DOI: 10.3389/fgene.2022.827560 . https://www.ncbi.nlm.nih.gov/pubmed/35692839 Cited in this article [1]

[40]

Zhou L, Chen J, Liu Q, et al. Case report: whole-exome sequencing identified two novel COMP variants causing pseudoachondroplasia[J]. Front Endocrinol (Lausanne), 2023, 14: 1267946. PMCID: PMC10702128. DOI: 10.3389/fendo.2023.1267946 . https://www.ncbi.nlm.nih.gov/pubmed/38075060 Cited in this article [1]

[41]

Ahmed HA, Elhossini R, Aglan M, et al. Aggrecan-related bone disorders; a novel heterozygous ACAN variant associated with spondyloepimetaphyseal dysplasia expanding the phenotypic spectrum and review of literature[J]. J Genet Eng Biotechnol, 2024, 22(1): 100341. PMCID: PMC10860877. DOI: 10.1016/j.jgeb.2023.100341 . https://www.ncbi.nlm.nih.gov/pubmed/38494255 Cited in this article [1]

[42]	Dy P, Wang W, Bhattaram P, et al. Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes[J]. Dev Cell, 2012, 22(3): 597-609. PMCID: PMC3306603. DOI: 10.1016/j.devcel.2011.12.024 . https://www.ncbi.nlm.nih.gov/pubmed/22421045 Cited in this article [1]

[43]

Wang L, Liu Z, Zhao S, et al. Variants in the SOX9 transactivation middle domain induce axial skeleton dysplasia and scoliosis[J]. Proc Natl Acad Sci U S A, 2025, 122(4): e2313978121. PMCID: PMC11789016. DOI: 10.1073/pnas.2313978121 . https://www.ncbi.nlm.nih.gov/pubmed/39854231 Cited in this article [1]

[44]

Rashid H, Chen H, Javed A. Runx2 is required for hypertrophic chondrocyte mediated degradation of cartilage matrix during endochondral ossification[J]. Matrix Biol Plus, 2021, 12: 100088. PMCID: PMC8586806. DOI: 10.1016/j.mbplus.2021.100088 . https://www.ncbi.nlm.nih.gov/pubmed/34805821 Cited in this article [1]

[45]	Zhang Y, Duan X. A novel 90-kbp deletion of RUNX2 associated with cleidocranial dysplasia[J]. Genes (Basel), 2022, 13(7): 1128. PMCID: PMC9322484. DOI: 10.3390/genes13071128 . https://www.ncbi.nlm.nih.gov/pubmed/35885911 Cited in this article [1]

[46]

Thakore P, Smith SS, Karki S, et al. miR-433 targets BMP and Indian hedgehog signaling to coordinate murine postnatal growth plate dynamics[J]. J Bone Miner Res, 2026, 41(5): 551-564. PMCID: PMC13078589. DOI: 10.1093/jbmr/zjaf182 . https://www.ncbi.nlm.nih.gov/pubmed/41342396 Cited in this article [1]

[47]

Zeng Y, Du C, Xiao P, et al. Sox9-increased miR-322-5p facilitates BMP2-induced chondrogenic differentiation by targeting Smad7 in mesenchymal stem cells[J]. Stem Cells Int, 2021, 2021: 9778207. PMCID: PMC8589527. DOI: 10.1155/2021/9778207 . https://www.ncbi.nlm.nih.gov/pubmed/34777504 Cited in this article [1]

[48]

Liu X, Yuan J, Wu Z, et al. Plasma exosome miRNA-26b-3p derived from idiopathic short stature impairs longitudinal bone growth via the AKAP2/ERK1/2 axis[J]. J Nanobiotechnology, 2023, 21(1): 94. PMCID: PMC10022307. DOI: 10.1186/s12951-023-01849-8 . https://www.ncbi.nlm.nih.gov/pubmed/36927779 Cited in this article [1]

[49]	Danowitz M, Grimberg A. Clinical indications for growth hormone therapy[J]. Adv Pediatr, 2022, 69(1): 203-217. PMCID: PMC9754707. DOI: 10.1016/j.yapd.2022.03.005 . https://www.ncbi.nlm.nih.gov/pubmed/35985710 Cited in this article [1]

[50]	Ziv-Baran T, Modan-Moses D, Zacay G, et al. Growth hormone treatment and the risk of adolescent scoliosis: a large matched cohort study[J]. Acta Paediatr, 2023, 112(6): 1240-1248. DOI: 10.1111/apa.16749 . https://www.ncbi.nlm.nih.gov/pubmed/36895108 Cited in this article [1]

[51]	Allen NG, Krishna KB, Lee PA. Use of gonadotropin-releasing hormone analogs in children[J]. Curr Opin Pediatr, 2021, 33(4): 442-448. DOI: 10.1097/MOP.0000000000001026 . https://www.ncbi.nlm.nih.gov/pubmed/34001716 Cited in this article [1]

[52]	Zhang Y, Yuan X, Mccormick K, et al. The efficacy and safety of rhGH treatment combined with letrozole/GnRHa in adolescent boys[J]. BMC Pediatr, 2025, 25(1): 59. PMCID: PMC11761712. DOI: 10.1186/s12887-025-05408-y . https://www.ncbi.nlm.nih.gov/pubmed/39856629 Cited in this article [1]

[53]	Rico-Llanos G, Czyrek AA, Krejci P. Oral infigratinib therapy in children with achondroplasia[J]. N Engl J Med, 2025, 392(23): 2388. DOI: 10.1056/NEJMc2504219 . https://www.ncbi.nlm.nih.gov/pubmed/40532160 Cited in this article [1]

[54]	Tailor K, van Ree J, Stowe T, et al. Efficacy of cartilage-targeted IGF-1 in a mouse model of growth hormone insensitivity[J]. Front Endocrinol (Lausanne), 2025, 15: 1523931. PMCID: PMC11756323. DOI: 10.3389/fendo.2024.1523931 . https://www.ncbi.nlm.nih.gov/pubmed/39850478 Cited in this article [1]

[55]	Angelozzi M, Molin A, Karvande A, et al. Fgfr3 enhancer deletion markedly improves all skeletal features in a mouse model of achondroplasia[J]. J Clin Invest, 2025, 135(2): e184929. PMCID: PMC11735107. DOI: 10.1172/jci184929 . https://www.ncbi.nlm.nih.gov/pubmed/39817451 Cited in this article [1]

[56]	Wang X, Li P, Muselmani MN, et al. Construction of growth plate organoids via a layered induction based in vitro 3D cultivation system[J]. Biomater Adv, 2026, 183: 214742. DOI: 10.1016/j.bioadv.2026.214742 . https://www.ncbi.nlm.nih.gov/pubmed/41643409 Cited in this article [1]